Your browser doesn't support javascript.
loading
Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance.
Dragano, Nathalia R V; Milbank, Edward; Haddad-Tóvolli, Roberta; Garrido-Gil, Pablo; Nóvoa, Eva; Fondevilla, Marcos F; Capelli, Valentina; Zanesco, Ariane Maria; Solon, Carina; Morari, Joseane; Pires, Leticia; Estevez-Salguero, Ánxela; Beiroa, Daniel; González-García, Ismael; Barca-Mayo, Olga; Diéguez, Carlos; Nogueiras, Ruben; Labandeira-García, José L; Rexen Ulven, Elisabeth; Ulven, Trond; Claret, Marc; Velloso, Licio A; López, Miguel.
Affiliation
  • Dragano NRV; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain; Laboratory of Cell Signaling-Obesity and Comorbidities Research Center, University of Campinas, Campinas, Brazil. Ele
  • Milbank E; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • Haddad-Tóvolli R; Neuronal Control of Metabolism (NeuCoMe) Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Garrido-Gil P; Department of Morphological Sciences, CiMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; CIBER Enfermedades Neurodegenerativas (CIBERNED), 28029, Santiago de Compostela, Spain.
  • Nóvoa E; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • Fondevilla MF; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • Capelli V; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • Zanesco AM; Laboratory of Cell Signaling-Obesity and Comorbidities Research Center, University of Campinas, Campinas, Brazil.
  • Solon C; Laboratory of Cell Signaling-Obesity and Comorbidities Research Center, University of Campinas, Campinas, Brazil.
  • Morari J; Laboratory of Cell Signaling-Obesity and Comorbidities Research Center, University of Campinas, Campinas, Brazil.
  • Pires L; Laboratory of Cell Signaling-Obesity and Comorbidities Research Center, University of Campinas, Campinas, Brazil.
  • Estevez-Salguero Á; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • Beiroa D; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • González-García I; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • Barca-Mayo O; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain.
  • Diéguez C; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • Nogueiras R; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain.
  • Labandeira-García JL; Department of Morphological Sciences, CiMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; CIBER Enfermedades Neurodegenerativas (CIBERNED), 28029, Santiago de Compostela, Spain.
  • Rexen Ulven E; Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
  • Ulven T; Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
  • Claret M; Neuronal Control of Metabolism (NeuCoMe) Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), 08036, Spain; Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain.
  • Velloso LA; Laboratory of Cell Signaling-Obesity and Comorbidities Research Center, University of Campinas, Campinas, Brazil.
  • López M; Department of Physiology, CiMUS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 15706, Spain. Electronic address: m.lopez@usc.es.
Mol Metab ; 79: 101840, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38036170
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pro-Opiomelanocortin / Fatty Acids, Nonesterified Limits: Animals Language: En Journal: Mol Metab Year: 2024 Document type: Article Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pro-Opiomelanocortin / Fatty Acids, Nonesterified Limits: Animals Language: En Journal: Mol Metab Year: 2024 Document type: Article Country of publication: Germany